Aspect Biosystems is a privately held biotechnology company operating at the leading edge of 3D-bioprinting and tissue engineering. Aspect’s Lab-on-a-Printer™ platform technology enables advances in understanding fundamental biology, disease research, development of novel therapeutics, and regenerative medicine. Aspect strategically partners with academic and industry partners to create physiologically and commercially relevant tissues to advance and accelerate the discovery and development of new therapies.
1781 75TH Ave West
Vancouver, BC V6P 6P2 Canada